#Latest news with #druginnovationWall Street Journal30-07-2025HealthWall Street JournalWSJ Opinion: The FDA's Gene-Therapy Reversal and the Exit of Vinay PrasadA top official at the Food and Drug Administration steps down after the agency changes course on a treatment for Duchenne muscular dystrophy. What does this say about the Trump Administration's approach toward drug innovation?
Wall Street Journal30-07-2025HealthWall Street JournalWSJ Opinion: The FDA's Gene-Therapy Reversal and the Exit of Vinay PrasadA top official at the Food and Drug Administration steps down after the agency changes course on a treatment for Duchenne muscular dystrophy. What does this say about the Trump Administration's approach toward drug innovation?
30-07-2025
